This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Dextrorphan: Difference between revisions
>Kenan m Remove style note |
>LockPicker standardizing |
||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{headerpanel|{{ | {{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}} | ||
{{headerpanel|{{approval}}}} | |||
{{SummarySheet}} | |||
{{SubstanceBox/DXO}} | |||
'''Dextrorphan''' (also known as '''DXO''') is a [[dissociative]] drug of the [[morphinan]] class. It's the main active metabolite of [[dextromethorphan]] ('''DXM'''). It appears as a colorless powder.<ref> | '''Dextrorphan''' (also known as '''DXO''') is a [[dissociative]] drug of the [[morphinan]] class. It's the main active metabolite of [[dextromethorphan]] ('''DXM'''). It appears as a colorless powder.<ref> | ||
"Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml</ref> | "Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml</ref> | ||
| Line 22: | Line 24: | ||
One user reported excessive itchiness accompanied by a "peaceful yet emotionless state" after 340mg of the substance was consumed.<ref> | One user reported excessive itchiness accompanied by a "peaceful yet emotionless state" after 340mg of the substance was consumed.<ref> | ||
"Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml</ref> | "Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student." Erowid DXM Vault : An Unpleasant Exploration of DXO, by Student. Erowid.org, 15 Sept. 2001. Web. 15 Apr. 2015 | https://www.erowid.org/chemicals/dxm/dxm_info3.shtml</ref> | ||
{{effects/base | |||
|{{effects/physical| | |||
*'''[[Effect::Appetite suppression]]''' | *'''[[Effect::Appetite suppression]]''' | ||
*'''[[Effect::Changes in felt bodily form]]''' | *'''[[Effect::Changes in felt bodily form]]''' | ||
| Line 35: | Line 38: | ||
*'''[[Effect::Tactile disconnection]]''' | *'''[[Effect::Tactile disconnection]]''' | ||
*'''[[Effect::Tactile suppression]]''' | *'''[[Effect::Tactile suppression]]''' | ||
}} | |||
|{{effects/cognitive| | |||
*'''[[Effect::Amnesia]]''' | *'''[[Effect::Amnesia]]''' | ||
*'''[[Effect::Conceptual thinking]]''' | *'''[[Effect::Conceptual thinking]]''' | ||
| Line 55: | Line 58: | ||
*'''[[Effect::Time distortion]]''' | *'''[[Effect::Time distortion]]''' | ||
*'''[[Effect::Unity and interconnectedness]]''' | *'''[[Effect::Unity and interconnectedness]]''' | ||
}} | |||
}} | |||
===Experience reports=== | |||
There are currently {{#ask:[[Category:DXO]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]]. | |||
{{#ask: [[Category:DXO]][[Category:Experience]]|format=ul|Columns=1}} | |||
Additional experience reports can be found here: | |||
*[https://www.erowid.org/experiences/subs/exp_DXO.shtml Erowid Experience Vaults: DXO] | |||
==Toxicity and harm potential== | |||
{{toxicity}} | |||
It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance. | |||
===Lethal dosage=== | |||
===Tolerance and addiction potential=== | |||
===Dangerous interactions=== | |||
{{DangerousInteractions}} | |||
{{DangerousInteractions/Intro}} | |||
{{DangerousInteractions/Dissociatives}} | |||
==Legal issues== | ==Legal issues== | ||
{{legalStub}} | {{legalStub}} | ||
* '''Germany | * '''Germany''': Dextrorphan is uncontrolled.{{citation needed|date=November 2020}} | ||
* '''Poland | * '''Poland''': Dextrorphan is unscheduled.<ref>List of scheduled substances in Poland. | http://www2.mz.gov.pl/wwwfiles/ma_struktura/docs/zal2_uopnarkomanii_29072005.pdf</ref> | ||
* '''United States | * '''United States''': Dextrorphan is unscheduled since October 1, 1976.<ref>DEA: "Lists of: Scheduling Actions Controlled Substances Regulated Chemicals"</ref> | ||
==See also== | ==See also== | ||
| Line 69: | Line 89: | ||
*[[Morphinan]] | *[[Morphinan]] | ||
*[[MXE]] | *[[MXE]] | ||
==External links== | |||
*[[wikipedia:Dextrorphan|Dextrorphan (Wikipedia)]] | |||
==References== | ==References== | ||
<references /> | <references /> | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category:Morphinan]] | [[Category:Morphinan]] | ||
[[Category:Dissociative]] | [[Category:Dissociative]] | ||
[[Category:Approval]] | |||
[[Category:Proofread]] | |||